Zoetis

Zoetis

Yahoo Finance • 3 days ago

Zoetis (ZTS) Says Study Shows Simparica Trio Outperformed A Rival On Resistant Heartworm

Zoetis (NYSE:ZTS) reported new peer-reviewed data on its Simparica Trio product comparing protection against resistant heartworm to NexGard Plus. The publication focuses on a resistant heartworm strain that has become a growing concern for... Full story

Yahoo Finance • 4 days ago

These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks

It's going to be a very long road back to all-time stock price highs for some well-known companies battling through challenging industry conditions and management missteps. Seven S&P 500 (^GSPC) stocks with market caps above $20 billion n... Full story

Yahoo Finance • 5 days ago

S&P 500 hits a record; These $20B stocks still need 200% to break even

[Abstract Data Chart] The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) tagged a fresh intraday record high on Tuesday morning, extending a bull market that began in October 2022. The milestone masks a sharp split inside the in... Full story

Yahoo Finance • 5 days ago

Burry flags six stocks as likely tax-loss sale candidates

Astrid Stawiarz Michael Burry outlined how he is positioning his portfolio for the fourth-quarter tax-loss harvesting season, highlighting six stocks that stand out as likely tax loss sale candidates that may not do well over the next cou... Full story

Yahoo Finance • 8 days ago

Vertex (VRTX) or Regeneron (REGN)? Two Biotech Moats, Two Very Different Bets

Biotech companies are strange businesses to think about in terms of competitive advantages. A software company can lock customers into an ecosystem for years. A manufacturer can have a cost advantage. A biotech company, meanwhile, can spen... Full story

Yahoo Finance • 12 days ago

Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks

Unpacking Q2 Earnings: Merck (NYSE:MRK) In The Context Of Other Branded Pharmaceuticals Stocks Looking back on branded pharmaceuticals stocks' Q2 earnings, we examine this quarter's best and worst performers, including Merck (NYSE:MRK) an... Full story

Yahoo Finance • 23 days ago

Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, Zoetis (ZTS) was down 2.22% at $71.40. This change lagged the S&P 500's 0.17% gain on the day. Elsewhere, the Dow saw a downswing of 0.18%, while the tech-heavy Nasdaq appreciated by 0.4%. The animal health co... Full story

Yahoo Finance • last month

Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For?

Photo by Pexels on Pixabay If you hold Pfizer (PFE) or Zoetis (ZTS), you hold the same idea: a branded medicine becomes a standard of care and keeps earning for years, in people or in animals. That is where it stops. Pfizer is buying repl... Full story

Yahoo Finance • last month

Michael Burry pulls back on risk, sheds December 2026 Nvidia and Palantir puts amid portfolio-wide cuts

[Financial Analyst Working on a Computer with Multi-Monitor Workstation with Real-Time Stocks, Commodities and Exchange Market Charts. Businessman Works in Investment Bank Downtown Office at Night.] gorodenkoff Michael Burry of 'The Big S... Full story

Yahoo Finance • last month

Zoetis (ZTS) Shares Drop After Earnings Revision

Impax Asset Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the "Impax US Sustainable Economy Fund". The letter can be downloaded here. The US Sustainable Economy portfolio ou... Full story

Yahoo Finance • last month

Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030

Company Logo 249-Page Report Delivers Country-by-Country Forecasts Across 15 Markets, Competitive Profiles of 32 Companies, and the Investment-Grade Data You Need to Act With Confidence Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Vet... Full story

Yahoo Finance • last month

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

PARSIPPANY, N.J., September 02, 2026--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, and Jay Saccaro, EVP, Chief Financial Officer and Chief Operating Officer, will participate in a fire... Full story

Yahoo Finance • last month

Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest

Branded Pharmaceuticals Stocks Q2 Teardown: Bristol-Myers Squibb (NYSE:BMY) Vs The Rest The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a look at how branded pharmac... Full story

Yahoo Finance • last month

Phibro Animal Health Q4 Earnings Call Highlights

Key Points Interested in Phibro Animal Health Corporation? Here are five stocks we like better. Record fiscal 2026 results: Phibro Animal Health reported sales of $1.518 billion, up 17%, while adjusted EBITDA rose 39% to $255 million. Gro... Full story

Yahoo Finance • 2 months ago

Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks

Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks Let's dig into the relative performance of Pfizer (NYSE:PFE) and its peers as we unravel the now-completed Q2 branded pharmaceuticals earnings season. Looking ahead, t... Full story

Yahoo Finance • 2 months ago

Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?

Zoetis Inc. (NYSE:ZTS) entered 2026 as a leader in animal health, but its latest earnings show that even a strong market position cannot fully insulate the company from weaker consumer demand. Fiscal Q2 2026 revenue remained flat at $2.5 b... Full story

Yahoo Finance • 2 months ago

3 of Wall Street’s Favorite Stocks We’re Skeptical Of

3 of Wall Street's Favorite Stocks We're Skeptical Of The stocks in this article have caught Wall Street's attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of sa... Full story

Yahoo Finance • 2 months ago

Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)

Reflecting On Branded Pharmaceuticals Stocks' Q2 Earnings: Corcept (NASDAQ:CORT) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Corcept (NASDAQ:CORT) and its... Full story

Yahoo Finance • 2 months ago

Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy?

Zoetis (NYSE:ZTS) is an animal health company. Michael Burry is long the stock, several media outlets reported, citing his Substack disclosures. The stock is down about 40% so far this year. Let's break down whether it's worth buying. Why... Full story

Yahoo Finance • 2 months ago

2 Large-Cap Stocks for Long-Term Investors and 1 We Avoid

2 Large-Cap Stocks for Long-Term Investors and 1 We Avoid Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much h... Full story